(Q40536260)

21 September 2017

Low-grade endotoxemia and platelet activation in cirrhosis (English)

1 reference

21 September 2017

1 reference

11

Francesco Violi

1 reference

21 September 2017

2

Stefania Basili

1 reference

21 September 2017

Valeria Raparelli

1

1 reference

21 September 2017

Roberto Carnevale

3

1 reference

21 September 2017

Laura Napoleone

4

1 reference

21 September 2017

Maria Del Ben

5

1 reference

21 September 2017

Cristina Nocella

6

1 reference

21 September 2017

Simona Bartimoccia

7

1 reference

21 September 2017

Cristina Lucidi

8

1 reference

21 September 2017

Giovanni Talerico

9

1 reference

21 September 2017

Oliviero Riggio

10

1 reference

21 September 2017

language of work or name

English

0 references

publication date

19 September 2016

1 reference

21 September 2017

1 reference

21 September 2017

65

1 reference

21 September 2017

2

1 reference

21 September 2017

571-581

1 reference

Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?

21 September 2017

1 reference

Clotting activation and hyperfibrinolysis in cirrhosis: implication for bleeding and thrombosis

21 January 2018

1 reference

Bleeding and thrombosis in cirrhotic patients: what really matters?

21 January 2018

1 reference

Portal vein thrombosis and chronic liver disease progression: The closer you look the more you see.

21 January 2018

1 reference

Polyunsaturated fatty acids balance affects platelet NOX2 activity in patients with liver cirrhosis

21 January 2018

1 reference

Mechanisms underlying the inhibitory effects of lipopolysaccharide on human platelet adhesion

21 January 2018

1 reference

Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway

21 January 2018

1 reference

Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress

21 January 2018

1 reference

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

Defective aggregation in cirrhosis is independent of in vivo platelet activation

21 January 2018

1 reference

Enhanced expression of monocyte tissue factor in patients with liver cirrhosis

21 January 2018

1 reference

Soluble P-selectin as a marker of in vivo platelet activation

21 January 2018

1 reference

gp91phox-dependent expression of platelet CD40 ligand

21 January 2018

1 reference

No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma.

21 January 2018

1 reference

The role of intestinal endotoxin in liver injury: a long and evolving history

21 January 2018

1 reference

Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia

21 January 2018

1 reference

Interactions between the intestinal microbiome and liver diseases

21 January 2018

1 reference

Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease.

21 January 2018

1 reference

Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications

21 January 2018

1 reference

Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.

21 January 2018

1 reference

Should the TermCoagulopathy in CirrhosisBe Abandoned?

21 January 2018

1 reference

NADPH oxidase-mediated platelet isoprostane over-production in cirrhotic patients: implication for platelet activation

21 January 2018

1 reference

The coagulopathy of chronic liver disease: Is there a causal relationship with bleeding? Yes

21 January 2018

1 reference

Inherited Human gp91 phox Deficiency Is Associated With Impaired Isoprostane Formation and Platelet Dysfunction

21 January 2018

1 reference

Lipopolysaccharide treatment reduces rat platelet aggregation independent of intracellular reactive-oxygen species generation

21 January 2018

1 reference

7 January 2021

Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation

1 reference

7 January 2021

Platelet Function: the Janus face of haemostasis in cirrhosis

1 reference

7 January 2021

High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia

1 reference

7 January 2021

Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.28853

1 reference

21 September 2017

1 reference